https://stock.noler.com/us/stock/kiromic-biopharma-inc https://stock.noler.com/us/stock/kiromic-biopharma-inc/accounts-payable https://stock.noler.com/us/stock/kiromic-biopharma-inc/accounts-receivable https://stock.noler.com/us/stock/kiromic-biopharma-inc/accrued-liabilities-and-other-liabilities https://stock.noler.com/us/stock/kiromic-biopharma-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/accumulated-depreciation https://stock.noler.com/us/stock/kiromic-biopharma-inc/additional-paid-in-capital https://stock.noler.com/us/stock/kiromic-biopharma-inc/adjustment-for-amortization https://stock.noler.com/us/stock/kiromic-biopharma-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/kiromic-biopharma-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/kiromic-biopharma-inc/asset-impairment-charges https://stock.noler.com/us/stock/kiromic-biopharma-inc/basic-shares https://stock.noler.com/us/stock/kiromic-biopharma-inc/capital-expenditures https://stock.noler.com/us/stock/kiromic-biopharma-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/kiromic-biopharma-inc/capitalized-computer-software-additions https://stock.noler.com/us/stock/kiromic-biopharma-inc/capitalized-computer-software-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/kiromic-biopharma-inc/cash-and-equivalents https://stock.noler.com/us/stock/kiromic-biopharma-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/kiromic-biopharma-inc/cash-and-restricted-cash-change-disposal-group-including-discontinued-operations https://stock.noler.com/us/stock/kiromic-biopharma-inc/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/kiromic-biopharma-inc/cash-flow-breakdown https://stock.noler.com/us/stock/kiromic-biopharma-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/kiromic-biopharma-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/kiromic-biopharma-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/kiromic-biopharma-inc/common-stock-dividends-per-share-cash-paid https://stock.noler.com/us/stock/kiromic-biopharma-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/kiromic-biopharma-inc/common-stock-value https://stock.noler.com/us/stock/kiromic-biopharma-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/kiromic-biopharma-inc/construction-in-progress-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/kiromic-biopharma-inc/construction-in-progress-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/kiromic-biopharma-inc/convertible-debt-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/convertible-subordinated-debt-noncurrent https://stock.noler.com/us/stock/kiromic-biopharma-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/kiromic-biopharma-inc/current-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/current-liabilities https://stock.noler.com/us/stock/kiromic-biopharma-inc/debt-carrying-amount https://stock.noler.com/us/stock/kiromic-biopharma-inc/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/kiromic-biopharma-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/kiromic-biopharma-inc/debt-face-amount https://stock.noler.com/us/stock/kiromic-biopharma-inc/debt-issuance-costs-incurred-during-noncash-or-partial-noncash-transaction https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-finance-costs-net https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-offering-costs https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-rent-credit-noncurrent https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-liabilities-leasing-arrangements https://stock.noler.com/us/stock/kiromic-biopharma-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/kiromic-biopharma-inc/defined-benefit-plan-contributions-by-employer https://stock.noler.com/us/stock/kiromic-biopharma-inc/depreciation https://stock.noler.com/us/stock/kiromic-biopharma-inc/diluted-shares https://stock.noler.com/us/stock/kiromic-biopharma-inc/dividends-payable-current-and-noncurrent https://stock.noler.com/us/stock/kiromic-biopharma-inc/dividends-preferred-stock https://stock.noler.com/us/stock/kiromic-biopharma-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/kiromic-biopharma-inc/effective-tax-rate https://stock.noler.com/us/stock/kiromic-biopharma-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/eps https://stock.noler.com/us/stock/kiromic-biopharma-inc/eps-basic https://stock.noler.com/us/stock/kiromic-biopharma-inc/financing-cash-flow https://stock.noler.com/us/stock/kiromic-biopharma-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/gain-loss-related-to-litigation-settlement https://stock.noler.com/us/stock/kiromic-biopharma-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/kiromic-biopharma-inc/general-and-administrative-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/goodwill https://stock.noler.com/us/stock/kiromic-biopharma-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/kiromic-biopharma-inc/grants-receivable https://stock.noler.com/us/stock/kiromic-biopharma-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/kiromic-biopharma-inc/income-tax https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/increase-decrease-in-unbilled-receivables https://stock.noler.com/us/stock/kiromic-biopharma-inc/insider-transactions-corporate-securities https://stock.noler.com/us/stock/kiromic-biopharma-inc/insider-transactions-corporate-securities/purchases https://stock.noler.com/us/stock/kiromic-biopharma-inc/insider-transactions-preferred https://stock.noler.com/us/stock/kiromic-biopharma-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/kiromic-biopharma-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/kiromic-biopharma-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/kiromic-biopharma-inc/interest-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/kiromic-biopharma-inc/interest-paid-net https://stock.noler.com/us/stock/kiromic-biopharma-inc/interest-payable-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/inventory https://stock.noler.com/us/stock/kiromic-biopharma-inc/inventory-adjustments https://stock.noler.com/us/stock/kiromic-biopharma-inc/inventory-valuation-reserves https://stock.noler.com/us/stock/kiromic-biopharma-inc/inventory-write-down https://stock.noler.com/us/stock/kiromic-biopharma-inc/investing-cash-flow https://stock.noler.com/us/stock/kiromic-biopharma-inc/lease-and-rental-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/kiromic-biopharma-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/kiromic-biopharma-inc/litigation-reserve-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/loans-payable-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/net-change-in-cash https://stock.noler.com/us/stock/kiromic-biopharma-inc/net-income https://stock.noler.com/us/stock/kiromic-biopharma-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/kiromic-biopharma-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/kiromic-biopharma-inc/net-rentable-area https://stock.noler.com/us/stock/kiromic-biopharma-inc/noncash-or-part-noncash-acquisition-net-nonmonetary-assets-acquired-liabilities-assumed https://stock.noler.com/us/stock/kiromic-biopharma-inc/notes-issued https://stock.noler.com/us/stock/kiromic-biopharma-inc/notes-payable-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/number-of-reportable-segments https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-cash-flow https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-expenses https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-income https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-cost https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-liability https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-liability-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-2 https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-right-of-use-asset-amortization-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-leases-future-minimum-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/kiromic-biopharma-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/kiromic-biopharma-inc/other-income https://stock.noler.com/us/stock/kiromic-biopharma-inc/other-noncash-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/other-noncurrent-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/other-nonoperating-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/other-nonoperating-income https://stock.noler.com/us/stock/kiromic-biopharma-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/kiromic-biopharma-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/kiromic-biopharma-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/kiromic-biopharma-inc/paid-in-kind-interest https://stock.noler.com/us/stock/kiromic-biopharma-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/kiromic-biopharma-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-shares-facts https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-dividends-income-statement-impact https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-liquidation-preference-value https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/kiromic-biopharma-inc/preferred-stock-value https://stock.noler.com/us/stock/kiromic-biopharma-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/kiromic-biopharma-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/kiromic-biopharma-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/property-plant-equipment https://stock.noler.com/us/stock/kiromic-biopharma-inc/public-float https://stock.noler.com/us/stock/kiromic-biopharma-inc/related-party-transaction-amounts-of-transaction https://stock.noler.com/us/stock/kiromic-biopharma-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/kiromic-biopharma-inc/repayments-of-debt https://stock.noler.com/us/stock/kiromic-biopharma-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/kiromic-biopharma-inc/research-and-development https://stock.noler.com/us/stock/kiromic-biopharma-inc/restricted-cash https://stock.noler.com/us/stock/kiromic-biopharma-inc/restricted-cash-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/retained-earnings https://stock.noler.com/us/stock/kiromic-biopharma-inc/revenue https://stock.noler.com/us/stock/kiromic-biopharma-inc/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/kiromic-biopharma-inc/secured-debt-current https://stock.noler.com/us/stock/kiromic-biopharma-inc/shareholders-equity https://stock.noler.com/us/stock/kiromic-biopharma-inc/shares-authorized https://stock.noler.com/us/stock/kiromic-biopharma-inc/shares-issued https://stock.noler.com/us/stock/kiromic-biopharma-inc/short-term-borrowings https://stock.noler.com/us/stock/kiromic-biopharma-inc/short-term-debt https://stock.noler.com/us/stock/kiromic-biopharma-inc/short-term-lease-cost https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-based-compensation https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/kiromic-biopharma-inc/stock-split-ratio https://stock.noler.com/us/stock/kiromic-biopharma-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/kiromic-biopharma-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/kiromic-biopharma-inc/total-assets https://stock.noler.com/us/stock/kiromic-biopharma-inc/total-liabilities https://stock.noler.com/us/stock/kiromic-biopharma-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/kiromic-biopharma-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/kiromic-biopharma-inc/utb-income-tax-penalties-and-interest-expense https://stock.noler.com/us/stock/kiromic-biopharma-inc/variable-lease-payment https://stock.noler.com/us/stock/kiromic-biopharma-inc/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/kiromic-biopharma-inc/write-off-of-deferred-debt-issuance-cost